Fundamentanlly good Stocks...

SCript : GSFC (Fertilisers)

Recommended on : 30th September 2005
Year Ended : 05-06 (U)
Industry : Fertilisers - Nitrogenous/Phosphate
Business Group : Joint Sector Holding
CEO : Mr.A K Luke
Company Name : Gujarat State Fertilizer & Chemicals Ltd.
Company Code : 500690
Face Value (Rs.) : 10.00
Book Value (Rs.) : 111.20
Equity (Cr) : 79.81
Promoter's Holding (%) : 37.84
Institutional Holding(%): 28.26
Market Cap (Cr) : 1102.40
BSE / NSE Volume : 5918863
P/E Ratio : 8.0
Sales (Cr) : 2606.70
OPM (%) : 16.8
Net Profit (Cr) : 138.10
Dividend (%) : 15.0
EPS (Rs) : 17.30
RONW (% ) : 28.2

Period Ended : 05-06
Sales (Cr) : 425.00
Sales Variation (%) : -5.0
OPM (%) : 24.3
Net Profit (Cr) : 70.20
Net Profit Variation : 900.0
TTM EPS (Rs) : 25.50


NOTE: Investors need their own analysis b4 investing or selling sares.


Seniors kindly post TA views on this share

From,

Arvind.K

Dear Friends,

I am herewith enclosed Report from KOTAK for TV18.

Cross check b4 u decide to buy or sell scripts.

From

Arvind.K

Attached Files

TV1820Sep202005.rar (98.5 KB, 12 views)

Script Name : Ranbaxy Group

Recommended on : 03 October 2005
Year Ended : 04-12
Industry : Pharmaceuticals
CEO : Dr.Brian W Tempest
Company Name : Ranbaxy Laboratories Ltd.
Company Code : 500302
Face Value (Rs.) : 5.00
Book Value (Rs.) : 134.70
Equity (Cr) : 186.10
Promoter's Holding (%) : 35.81
Institutional Holding(%): 36.62
Market Cap (Cr) : 9229.50
BSE / NSE Volume : 14163599
P/E Ratio : 57.70
Sales (Cr) : 3497.00
OPM (%) : 12.40
Net Profit (Cr) : 528.00
Dividend (%) : -
EPS (Rs) : 28.40
RONW (% ) : 22.00

Period Ended : 05-06
Sales (Cr) : 953.00
Sales Variation (%) : 8.0
OPM (%) : 7.6
Net Profit (Cr) : 76.50
Net Profit Variation : -59.0
TTM EPS (Rs) : 9.00


Recent / Past News :
29.09.2005 : Ranbaxy Laboratories Ltd has announced
that the Company has received approval from the U S Food and Drug
Administrative to manufacture and market Pseudoephedrine
Hydrochloride Extended-Release Tablets USP, 120 mg. The Office of
generic Drugs, US Food and Drug Administrative, has determined the
Company's formulation to be bioequivalent and have the same
therapeutic effect as that of the reference listed drug Sudafed 12
Hour Extended- Release Tablets, 120 mg of Warner Lambert Co. Total
annual market sales for Pseudoephedrine Hydrochloride Extended-
Release Tablets USP, 120 mg were $ 16 million.
Pseudoephedrine Hydrochloride Extended Release Tablets USP, 120 mg
temporarily relieves nasal congestion due to the common cold, hay
fever or other respiratory allergies and nasal congestion associated
with sinusitis and temporarily relieves sinus congestion and
pressure.
We are delighted to receive yet another FDA approval in 2005 that
will be commercialized by Ohm Laboratories, our OTC Sales and
Marketing Division, "according to Venkat Krishna, Vice President, of
Ranbaxy Inc. "Ranbaxy and Ohm Labs feel this product is a great
addition to out portfolio and product will be introduced as soon as
sufficient quantities are manufactured to support the need of the
marketplace. We will be speaking to our customers immediately
regarding arrangements to secure this product," as commented by
Robert Haywood, Senior Director - Sales and Marketing for Ohm
Laboratories.
Ranbaxy Pharmaceuticals Inc. (RPI) based in Jacksonville, Florida,
and Ohm Laboratories, based in North Brunswick, New Jersey are both
wholly owned subsidiaries of the Company, RPI is engaged in the sale
and distribution of generic and branded prescription products in the
U.S. healthcare system and Ohm Laboratories is engaged in the
manufacture and sale of over the counter (OTC) products.

30.09.2005 : Ranbaxy Laboratories Ltd has announced
that the World Health Organisation (WHO), Geneva, has placed another
of the Companys Anti Retrovirals (ARV) on its pre-qualification
list. The product approved by WHO most recently is Nevirapine
tablets 200 mg. Nevirapine is a non-nucleoside reverse transcriptase
inhibitor and is widely used as part of first line Anti Retroviral
treatment around the world. In order to reduce mother to child
transmission, use of Nevirapine is also recommended in HIV infected
women in labour who have had no prior ARV therapy.
Commenting on the development, Dr. Brian Tempest, Chief Operating
Officer & Managing Director, of the Company said, We are glad that
our Nevirapine is now on the WHO list and more patients can access
this vital ARV at cost effective prices.
Companys Nevirapine tablets are already approved by USFDA and are
eligible for use in programmes funded by the US Presidents Emergency
Plan for AIDS relief (PEPFAR).
The Companys ARVs including Nevirapine, are manufactured at the
Company's state-of-the-art manufacturing facilities, that have been
inspected and approved by some of the most stringent agencies in the
world, including USFDA and WHO. The Contract Research Organisations
(CROs) used by the Company to carry out bio-equivalence studies for
its ARVs are globally reputed and conduct and file their studies
routinely with some of the most stringent regulatory authorities
around the world. The CROs also regularly undergo routine audits by
these regulatory authorities.
Since 2001, the Company has been providing ARV medicines of high
quality at affordable prices to AIDS/HIV affected countries for
patients who might not otherwise be able to gain access to this
therapy. The Companys ARVs have been used as mainstays in various
large treatment programs, both National and NGO/Institutional with
good results. The Company is committed to support this humanitarian
effort as a further means of lending support to the global fight
against HIV/AIDS.



B4 Investing kindly check urself .

From,
Arvind.K

Company Name : IVRCL Infrastructure & Projects Ltd.


Recommended on : 03 October 2005
Year Ended : 05-03
Industry : Construction & Contracting - Civil
Business Group : -
CEO : Mr.E Sudhir Reddy
Company Code : 530773
Face Value (Rs.) : 10.00
Book Value (Rs.) : 188.00
Equity (Cr) : 20.65
Promoter's Holding (%) : 13.75
Institutional Holding(%): 29.43
Market Cap (Cr) : 1409.00
BSE / NSE Volume : 4325569
P/E Ratio : 26.90
Sales (Cr) : 1055.00
OPM (%) : 8.20
Net Profit (Cr) : 56.70
Dividend (%) : 30.0
EPS (Rs) : 27.50
RONW (% ) : 29.6

Period Ended : 05-06
Sales (Cr) : 300.70
Sales Variation (%) : 28.0
OPM (%) : 7.8
Net Profit (Cr) : 17.10
Net Profit Variation(Rs): 59.00
TTM EPS (Rs) : 30.10



Recent / Past News :
26.09.2005 : SBI Funds Management Pvt. Ltd has informed
that SBI Mutual Fund under its various schemes has acquired 79,500
shares aggregating to 0.3718% of Ivrcl Infrastructures & Projects
Ltd. on September 22, 2005. The mode of purchase is Market Purchase
and the shareholding of SBI Mutual Fund under its various schemes
after the said acquisition is 1,075,386 shares aggregating to
5.0288% of the total paid up capital of IVRCL Infrastructures &
Projects Limited.
28.09.2005 : IVRCL Infrastructures & Projects Ltd has
informed that the Company on September 23, 2005 has allotted 1500
shares under ESOP 2000 scheme in conversion of 1500 options issued
to the employees having received the full consideration @ Rs 10/-
each options.

B4 investing kindly check urself.

from,
Arvind K

Dear Friends,

This was the Newsletter from 10 paisa and i post it here for my Traderji.com friends.I am investing the amount for these newsletters.Kindly Cross check urself b4 investing in any stocks.

Newsletter dated 9/10/2005
S.No.Scrips BSE Code Recomm. Rates Target Rates
1.Media Video Ltd 530435 32.00 40.00
2.Indo Count Industries 521016 32.20 41.00
3.Hindustan Motors 500500 40.90 52.00
4.Flex Engineering 522167 43.05 54.00
5.Essar Steel Ltd 500627 52.35 65.00
Target rates are expected in three to four months frame
of time,but we recommend you that whenever any scrip touches its
target rate,you must dispose of all shares or in parts(If you have
invested in that scrip),so that you may be able to invest those
funds in other scrips recommended in further newsletters.
Best of luck,
For midcaps.in
P.R.O.

NOTE:-AS THERE IS PANIC FOR SMALL & MIDCAP STOCKS AND MARKETS
ARE IN CORRECTION PHASE NOW A DAYS,SO WE ARE RECOMMENDING SOME
SCRIPS IN THIS NEWSLETTER, WHICH HAVE BEEN RECOMMENDED BY US IN
PREVIOUS NEWSLETTERS TOO,BUT LOOK ATTRACTIVE AT CURRENT PRICES.
AS YOU WILL ENTER AT THESE LEVELS,SO YOUR TARGET RATES WILL BE
DIFFERENT FROM THE PREVIOUS TARGETS TOO.IF YOU HAVE ALREADY
INVESTED IN THESE SCRIPS,THEN YOU HAVE TO WAIT.

DETAILED ANALYSIS OF STOCKS RECOMMENDED IN NEWSLETTER DATED 9/10/2005:-

1.Media Video Ltd

Scrip Code : 530435 Company Name : MEDIA VIDE L
Date Begin:01 Apr 2005 Date End:30 Jun 2005

Description Value(Rs. million)
Net Sales 370.09
Other Income 1.86
Total Income 371.94
Expenditure -348.8
Operating Profit 23.14
Interest -9.76
Gross Profit 13.39
Depreciation -2.53
Profit before Tax 10.86
Tax 7.16
Profit after Tax 18.02
Net Profit 18.02
Equity Capital 152.74
Conclusion-After analysing the results for first quarter of year 2005-2006,Media Video Ltd is a good buy at Rs.32.00/-.It can touch Rs.40/- in short to medium term.
************************************************** ***********************

2.Indo Count Industries

Scrip Code : 521016 Company Name : INDO COUNT I
Date Begin:01 Apr 2004 Date End:31 Mar 2005

Description Value(Rs. million)
Net Sales 1750
Other Income 43.1
Total Income 1793.1
Expenditure -1610.5
Operating Profit 182.6
Interest -53.1
Gross Profit 129.5
Depreciation -82.1
Profit before Tax 47.4
Tax -3.8
Profit after Tax 43.6
Net Profit 43.6
Equity Capital 235.4
************************************************** ***********************
Scrip Code : 521016 Company Name : INDO COUNT I
Date Begin:01 Apr 2005 Date End:30 Jun 2005

Description Value(Rs. million)
Net Sales 499.7
Other Income 8.1
Total Income 507.8
Expenditure -453.6
Operating Profit 54.2
Interest -12
Gross Profit 42.2
Depreciation -20.7
Profit before Tax 21.5
Tax -2
Profit after Tax 19.5
Net Profit 19.5
Equity Capital 235.4
Conclusion-After analysing the results for first quarter of year 2005-2006,Indo Count Industries is a good buy at Rs.32.20/-.It can touch Rs.41/- in short to medium term.
************************************************** ************************
3.Hindustan Motors

Scrip Code : 500500 Company Name : HIND MOT LTD
Date Begin:01 Apr 2005 Date End:30 Jun 2005

Description Value(Rs. million)
Net Sales 2113.4
Other Income 1926.8
Total Income 4040.2
Expenditure -2409.7
Operating Profit 1630.5
Interest -91.7
Gross Profit 1538.8
Depreciation -97.5
Profit before Tax 1441.3
Tax -415.8
Profit after Tax 1025.5
Net Profit 1025.5
Equity Capital 1611.7
Conclusion-After analysing the results for first quarter of year 2005-2006,Hindustan Motors is a good buy at Rs.40.90/-.It can touch Rs.52/- in short to medium term.
************************************************** ****************************

4.Flex Engineering

Scrip Code : 522167 Company Name : FLEX ENGINEE
Date Begin:01 Apr 2004 Date End:31 Mar 2005

Description Value(Rs. million)
Gross Sales -
Excise Duty -
Net Sales 508.8
Other Income 18.7
Total Income 527.5
Expenditure -416.7
Operating Profit 110.8
Interest -9.9
Gross Profit 100.9
Depreciation -23.6
Profit before Tax 77.3
Tax - 17.1
Profit after Tax 60.2
Net Profit 60.2
Equity Capital 171.7
************************************************** ****************************

Scrip Code : 522167 Company Name : FLEX ENGINEE
Date Begin:01 Apr 2005 Date End:30 Jun 2005

Description Value(Rs. million)
Gross Sales -
Excise Duty -
Net Sales 105.6
Other Income 1.9
Total Income 107.5
Expenditure -80.4
Operating Profit 27.1
Interest -2.4
Gross Profit 24.7
Depreciation -5.3
Profit before Tax 19.4
Tax - 3.5
Profit after Tax 15.9
Net Profit 15.9
Equity Capital 171.7
Conclusion-After analysing the results for first quarter of year 2005-2006,Flex Engineering is a good buy at Rs.43.05/-.It can touch Rs.54/- in short to medium term.
************************************************** ****************************
5.Essar Steel Ltd

Scrip Code : 500627 Company Name : ESSAR
Date Begin:01 Apr 2005 Date End:30 Jun 2005

Description Value(Rs. million)
Gross Sales 18129.5
Excise Duty -1626.9
Net Sales 16502.6
Other Income 26.3
Total Income 16528.9
Expenditure -11140.3
Operating Profit 5388.6
Interest -1083
Gross Profit 4305.6
Depreciation -981.7
Profit before Tax 3323.9
Tax -1246.8
Provisions and Contingencies -
Profit after Tax 2077.1
Extraordinary Items -
Prior Period Items -
Net Profit 2077.1
Equity Capital 3043.9
Conclusion-After analysing the results for first quarter of year 2005-2006,Essar Steel Ltd is a good buy at Rs.52.35/-.It can touch Rs.65/- in short to medium term.
************************************************** ********


from

Arvind.K

Thank you for your generosity & sharing with all of us Arvind.

A letter from pennyshares.in (9/10/2005)

Friends,

this newsletter FROM PENNYSHARES.IN and invest in Penny stocks is
Very High risk and Be cautious.

Newsletter dated 9/10/2005
S.No.Scrips BSE Code Recomm. Rates Target Rates
1.Xo Infotech 532116 7.35 10.00
2.RTCL 531552 7.51 10.00
3.Computer Point 507833 8.67 12.00
4.Shree Hari Chemicals 524336 9.50 13.00
5.Nutraplus Products 524764 9.64 13.00
Target rates are expected in three to four months frame
of time,but we recommend you that whenever any scrip touches its
target rate,you must dispose of all shares or in parts(If you have
invested in that scrip),so that you may be able to invest those
funds in other scrips recommended in further newsletters

I SEND IT FOR OUR FRIENDS

From,

Arvind.K

Script Name :Spanco Telesystems & Solutions Ltd.

Recommended on : 8th October 2005
Year Ended : 05-03
Industry : IT Enabled Services
Business Group : -
CEO : Mr.Rajesh Chhabria
Company Name : Spanco Telesystems & Solutions Ltd.
Company Code : 5008976
Face Value (Rs.) : 10.0
Book Value (Rs.) : 35.80
Equity (Cr) : 17.0
Promoter's Holding (%) : 40.54
Institutional Holding(%): 14.22
Market Cap (Cr) : 353.00
BSE / NSE Volume : 13739124
P/E Ratio : 32.10
Sales (Cr) : 61.20
OPM (%) : 18.70
Net Profit (Cr) : 6.30
Dividend (%) : -
EPS (Rs) : 3.70
RONW (% ) : 24.0

Period Ended : 05-06
Sales (Cr) : 36.50
Sales Variation (%) : 121.0
OPM (%) : 22.4
Net Profit (Cr) : 3.20
Net Profit Variation : 128.0
TTM EPS (Rs) : 6.80


Recent / Past News :
17.09.2005 Spanco Telesystems and Solutions Ltd has informed that
the Board of the Directors of the Company at its meeting held on
September 17, 2005, has issued and allotted the following securities
on preferential basis :
1. 29,80,000 Equity shares of Rs 10/- each for cash at a price of Rs
90.90 each at a premium of Rs 80.90 per share to Reliance Capital
Ltd.

2. 15,70,000 warrants for cash at a price of Rs 90.90 each, carrying
an option / entitlement to subscribe for even number of equity
shares of Rs 10/- each at a premium of Rs 80.90 per shares within a
period of 18 months from the date of this allotment to the following
allottees :

a. Reliance Capital Ltd - 5,70,000 warrants. b. Micro Management
Ltd - 5,00,000 warrants. c. Doyen Marketing Pvt. Ltd - 5,00,000
warrants.

Kindly think b4 Investing.

From,

Arvind.K

Script Name: ING VYsys Bank

Year Ended : 05-03
Industry : Banks - Private Sector
Business Group : -
CEO : -
Company Name : ING Vysya Bank Ltd.
Company Code : 531807
Face Value (Rs.) : 10.00
Book Value (Rs.) : 99.10
Equity (Cr) : 90.49
Promoter's Holding (%) : 44.13
Institutional Holding(%): 28.39
Market Cap (Cr) : 1545.20
BSE / NSE Volume : 1605281
P/E Ratio : -
Sales (Cr) : 1111.11
OPM (%) : 50.44
Net Profit (Cr) : -38.24
Dividend (%) : -
EPS (Rs) : -
RONW (% ) : 9.83

Period Ended : 05-06
Sales (Cr) : 330.30
Sales Variation (%) : 11.0
OPM (%) : 61.8
Net Profit (Cr) : 9.2
Net Profit Variation : L2P
TTM EPS (Rs) : -

B4 Investing Think

From,

Arvind.K

Script Name : TATA MOTORS

Year Ended : 05-03

Industry : Auto - LCVs/HCVs
Business Group : Tata Group
CEO : Mr.Ravi Kant

Company Name : Tata Motors Ltd.
Company Code : 500570
Face Value (Rs.) : 10.00
Book Value (Rs.) : 113.60
Equity (Cr) : 361.79
Promoter's Holding (%) : 32.35
Institutional Holding(%): 35.26
Market Cap (Cr) : 19762.50
BSE / NSE Volume : 18247860
P/E Ratio : 14.40
Sales (Cr) : 17419.13
OPM (%) : 12.10
Net Profit (Cr) : 1247.32
Dividend (%) : 125.0
EPS (Rs) : 34.60
RONW (% ) : 26.2

Period Ended : 05-06
Sales (Cr) : 3878.10
Sales Variation (%) : 9.0
OPM (%) : 12.4
Net Profit (Cr) : 273.40
Net Profit Variation : 22.0
TTM EPS (Rs) : 33.50





Recent / Past News :
04.10.2005 Tata Motors Ltd, has announced that Tata
Technologies Ltd (TTL), through its subsidiary, Tata Technologies
Inc., USA (TTUS) has received unconditional acceptance of
approximately 92.5% of the equity shares of INCAT International Plc,
a UK-based Company listed on the Alternative Investment Market (AIM)
of the London Stock Exchange, for which it had made a cash offer.
As of October 03, 2005, valid acceptances of the offer had been
received in respect of a total of 22,448,051 INCAT shares comprising
approximately 92.5% of INCAT's existing issued ordinary share
capital. The offer will remain open for acceptance until further
notice.

TTUS had made a cash offer at 220 pence per share (Rs 169.40 per
share). The offer price had represented a 4% premium on INCAT's
closing price of 211.5 pence per share, as on August 17, 2005, when
TTUS made an open offer to acquire INCAT International.

Both Tata Technologies and INCAT provide engineering and design
services and PLM (product lifecycle management) products and
services, primarily to manufacturers and their suppliers in the
international automotive, aerospace and engineering markets.

The offshore capabilities of Tata Technologies in the field of
engineering automation services combined with the high-end onshore
strengths of INCAT are expected to offer a strong and seamless
onshore / offshore delivery capability to the international
customers in the automotive, aerospace and engineering industries.

Tata Technologies and INCAT together have a combined turnover of
approximately Rs 6956 million. The new combined entity services some
of the world's best-known names in automotive, aerospace and
engineering industries in North America, Europe and Asia-Pacific.
They together, as a leading end-to-end automotive engineering and
design services company, will create greater value for their
customers by combining state-of-the-art technologies with a real-
world understanding of engineering and manufacturing processes, to
bring down costs and reduce time to market.


04.10.2005 Mumbai: Tata Motors on October 3 reported a
total sale of 40,095 vehicles (including exports) for September
2005, a growth of 13.24 per cent over 35,406 vehicles sold in the
same period last year. Cumulative sales for the company at 1,94,966
units were growing by 8 per cent. Sale of commercial vehicles in
September in the domestic market was at 19,087 units (17,179 units),
an increase of 11.1 per cent. M&HCV sales stood at 11,331 units
while LCV sales stood at 7,756 units. Cumulative sales for the
fiscal were 87,345 units (83,954 units). The passenger vehicle
business reported a total sale of 16,078 vehicles last month an
increase of one per cent. The Indica sold 9,669 units (9,256 units)
and The Indigo family registered sales of 3,354 units (3,818 units).
The Sumo and Safari accounted for sales of 3,055 units (2,852
units).
Cumulative sales of passenger vehicles in the domestic market for
the fiscal were 84,142 units (85,948 units). The company's exports
were 4,930 vehicles in September 2005 compared to 2,301 vehicles in
September 2004, up by 114.3 per cent. The cumulative sales from
exports in the current period at 23,479 nos have recorded a 121.7
per cent growth over the corresponding figures for the previous
period.


From,

Arvind.K